期刊文献+

胆固醇酯转运蛋白(CETP)―TaqIB基因多态性与散发性阿尔茨海默病相关性研究 被引量:1

Relationship Between Cholesteryl Ester Transfer Protein(CETP)-TaqIB Gene Polymorphism and Sporadic Alzheimer's Disease
原文传递
导出
摘要 目的:研究散发性阿尔茨海默病(sporadic Alzheimer’disease,SAD)患者和正常老年人之间血清脂质水平、认知功能的差异;探讨胆固醇酯转运蛋白(CETP)-TaqIB基因多态性与SAD的关系及其对认知功能的影响。方法:对100例散发性阿尔茨海默病患者和102例健康对照者进行简易精神状态量表(MMSE)、Hachinski缺血指数量表(HIS)评分,其中49例轻-中度AD患者、61例健康对照者接受韦氏记忆量表(WMS)及威斯康辛卡片分类测验(WCST)的测量;采用氯仿法抽提外周血白细胞基因组DNA、多聚酶链式反应和限制性片段长度多态性法(PCR-RFLP)测定CETP-TaqIB基因型。结果:AD组血清胆固醇水平高于对照组(P<0.05);AD组中CETP-TaqIB三种基因型频率分别为B1B1 35%、B1B2 48%、B2B2 17%,CETP-TaqIB基因型和等位基因频率分布在阿尔茨海默病组(AD)与对照组之间无显著性差异(P>0.05);研究总人群中,CETP-TaqIB三种基因型的WMS各分测验成绩差异无显著性(P>0.05),而B2等位基因携带者长时记忆评分高于B1B1纯合子(P<0.05);B1B1、B1B2和B2B2基因型的WCST中完成分类数呈下降趋势,持续性反应呈上升趋势,但差异无统计学意义(P>0.05)。结论:CETP-TaqIB基因多态性与阿尔茨海默病发病无关,CETP-TaqIB基因多态性可能与老年人长时记忆功能差异有关。 Objective: To explore the difference in the cognition function and the level of blood profile between Alzheimer's disease patients and healthly aged controls.To investigate the association beween the cholesteryl ester transfer protein(CETP) TaqIB polymorphism and Alzheimer's disease,and the patient's cognition function.Methods: 100 AD patients and 102 controls were assessed with mini-mental state examination(MMSE) and Hachinski ischemic score(HIS);at the same time,49 mild-to-modetate patients with AD and 61 healthy controls were assessed with Wechsler Memory Scale(WMS) and Wisconsin card sorting test(WCST).Polymerase chain reaction-restricted fragments length polymorphism(PCR-RFLP) was used to determine CETP-TaqIB gene polymorphism.Results: The CETP-TaqIB genotype frequencies of AD patients were B1B1 35%、B1B2 48% and B2B2 17%.There was no significant association in CETP-TaqIB genotype and allele distribution between AD patients and the healthy controls(P0.05).In the study population,there was no significant difference in the score of WMS among CETP-TaqIB B1B1 genotype,B1B2 genotype and B2B2 genotype,but B2 allel gene had higher score than B1B1 gentype(P0.05);Complete classification number was gradually reduced among the three genotypes.Sustained response was gradually increased,but there were no obvious differences.Conclusion: There was no obvious correlation between CETP-TaqIB gene polymorphism and Alzheimer's disease,CETP-TaqIB polymorphism might be associated with long-term memory in elder people.
出处 《中国临床心理学杂志》 CSSCI CSCD 北大核心 2012年第5期619-622,共4页 Chinese Journal of Clinical Psychology
基金 湖南省科技厅计划项目(2009FJ3054)
关键词 阿尔茨海默病 CETP-TaqIB 胆固醇 认知功能 Cholesterol CETP-TaqIB Alzheimer's disease Cognition
  • 相关文献

参考文献10

  • 1Rodriguez E, Mateo I, Infante J, et al.Cholesteryl ester tran- sfer protein(CETP) polymorphism modifies the Alzheimer's disease risk associated with ApoE epsilon4 allele. J Neurol, 2006, 253(2): 181-185.
  • 2Ehehalt R, Keller P, Haass C, et al.Amyloidogenic process- ing of the Alzheimer's disease amyloid precursor protein depends on lipid rafts. J Cell Biol, 2006, 160(1): 113-123.
  • 3Hur JY, Welander H, Behbahani H, et al. Active P-secre- tase is localized to detergent-resistant membranes in human brain. FEBS Journal, 2008; 275(6):.
  • 4Osenkowski P, Ye W, Wang R, et al. Direct and potent reg- ulation of T3-secretase by its lipid microenvironment. Jour- nal of Biological Chemistry, 2008, 283(33): 22529-22540.
  • 5龚耀先.修订韦氏记忆量表手册(WMS).第2版.长沙:湖南医科大学.1989.10-19.
  • 6Sanders AE, Wang C, Kaz M, et al. Association of a func- tional polymorphism in the cholesteryl ester transfer protein gene with memory decline and incidence of dementia. JAMA, 2010, 303(2): 150-158.
  • 7Anstey K J, Lipnicki DM, Low LF. Cholesterol as a risk fac- tor for dementia and cognitive decline: A systematic review of prospective studies with meta-analysis. Am J Geriatr Psychiatry, 2008, 16(5): 343-354.
  • 8Arias-V6squez A, Isaacs A, Aulchenko YS, et al. The cholesteryl ester transfer protein(CETP) gene and the risk of Alzheimer' s disease. Neurogenetics, 2007, 8(3): 189-193.
  • 9陈大伟,陈彪,杨静芳,冯秀丽,汤哲,董秀敏.胆固醇酯转运蛋白基因多态性与阿尔茨海默病的关系[J].中华神经科杂志,2006,39(12):814-817. 被引量:8
  • 10Swanberg MM, Tractenberg RE, Mohs R, et al. Executive dysfunction in Alzheimer's disease. Arch Neurol, 2004, 61: 556-560.

二级参考文献19

  • 1王伟,周新,刘芳,胡汉宁,韩定芬.胆固醇酯转运蛋白基因TaqIB多态性、D442G突变与冠心病的相关性研究[J].中华心血管病杂志,2004,32(11):981-985. 被引量:17
  • 2陈宝生 乔家治 乔采莲 等.载脂蛋白E等位基因频率的种族差异—中国人群与西方人群比较[J].中国医学科学院学报,1987,9:398-398.
  • 3Mickikawa M.Cholesterol paradox:is high total or low HDL cholesterol level a risk for Alzheimer's disease? J Neurosci Res,2003,72:141-146.
  • 4Chong PH,Kezele R,Franklin C.High-density lipoprotein cholesterol and the role of statins.Circ J,2002,66:1037-1044.
  • 5Frikke-Schmidt R,Nordestgaard BG,Agerholm-Larsen B,et al.Context-dependent and invariant associations between lipids,lipoproteins,and apolipoproteins and apolipoprotein E genotype.J Lipid Res,2000,41:1812-1822.
  • 6van der Steeg WA,Kuivenhoven JA,Klerkx AH,et al.Role of CETP inhibitors in the treatment of dyslipidemia.Curr Opin Lipidol,2004,15:631-636.
  • 7Yamashita S,Hirano K,Sakai N,et al.Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein.Biochim Biophys Acta,2000,1529:257-275.
  • 8Rodriguez E,Mateo I,Infante J,et al.Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele.J Neurol,2006,253:181-185.
  • 9Arai H,Yamamoto A,Matsuzawa Y,et al.Polymorphisms in four genes related to triglyceride and HDL-cholesterol levels in the general Japanese population in 2000.J Atheroscler Thromb,2005,12:240-250.
  • 10Boekholdt SM,Thompson JF.Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease.J Lipid Res,2003,44:1080-1093.

共引文献7

同被引文献17

  • 1王跃春.大鼠Y-型迷宫测试法的筛选与优化[J].中国行为医学科学,2005,14(1):50-52. 被引量:42
  • 2Kessels RP, Feijen J, Postma A. Implicit and explicit memo- ry for spatial information in Alzheimer' s disease. Dement Geriatr Cogn Disord, 2005, 20(2-3): 184-191.
  • 3Beaunieux H, Eustache F, Busson P, et al. Cognitive proce- dural learning in early Alzheimer' s disease: impaired pro- cesses and compensatory mechanisms. J Neuropsychol, 2012, 6(1): 31-42.
  • 4Burghaus L, Schtitz U, Krempel U, et al. Quantitative assess- ment of nicotinic acetylcholine receptor proteins in the cere- bral cortex of Alzheimer patients. Brain Res Mol Brain Res, 2000, 76(2): 385-388.
  • 5Kadir A, Darreh-Shori T, Almkvist O, et al. Changes in brain l lC-nicotine binding sites in patients with mild A1- zheimer' s disease following rivastigmine treatment as as- sessed by PET. Psychopharmacology(Berl), 2007, 191(4): 1005-1014.
  • 6Ni R, Marutle A, Nordberg A. Modulation of tx7 nicotinic acetylcholine receptor and fibrillar amyloid-β interactions in Alzheimer' s disease brain. J Alzheimers Dis, 2013, 33(3): 841-851.
  • 7D' Andrea MR, Nagele RG. Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer' s disease pyramidal neurons. Curr Pharm Des, 2006, 12(6): 677-684.
  • 8Maurice T, Lockhart BP, Privat A. Amnesia induced in mice by centrally administered beta-amyloid peptides in- volves eholinergic dysfunction. Brain Res, 1996, 706: 181- 193.
  • 9Klimkowicz-Mrowiec A, Slowik A, Krzywoszanski L. Severi- ty of explicit memory impairment due to Alzheimer' s disea- se improves effectiveness of implicit learning. J Neurol, 2008, 255(4): 502-509.
  • 10Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods, 1984, 11:47-60.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部